Diagnosing and Grading Gliomas Using a Proteomics Approach

Summary

This technology provides for a proteomic approach to grading gliomas, and for predicting patient survival. In addition to employing global protein expression patterns, such as by mass spectrometry, particular target proteins whose expression is altered in various gliomas can be used to predict the stage/classification of a glioma, as well as to indicate whether a given patient will be a short- or long-term survivor.

 

Website

U.S. Patent 7,799,519: Diagnosing and grading gliomas using a proteomics approach


Licensing Contact

Karen Rufus

615.322.4295
Tech ID:
VU0562

Inventors

Richard Caprioli
Diagnostics